Cargando…
Rituximab-Associated Flare of Cryoglobulinemic Vasculitis
BACKGROUND: Patients with cryoglobulinemic vasculitis (CV) can develop disease flare after rituximab administration. The objective of our study was to describe the prevalence, clinical characteristics, predisposing factors, and outcomes of patients with rituximab-associated flare of CV. METHODS: We...
Autores principales: | Sy-Go, Janina Paula T., Thongprayoon, Charat, Herrera Hernandez, Loren P., Zoghby, Ziad, Leung, Nelson, Manohar, Sandhya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589694/ https://www.ncbi.nlm.nih.gov/pubmed/34805636 http://dx.doi.org/10.1016/j.ekir.2021.08.024 |
Ejemplares similares
-
Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis
por: Fornero, Léa, et al.
Publicado: (2023) -
Rituximab for Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis
por: Lioger, Bertrand, et al.
Publicado: (2016) -
A Flare of Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis After COVID-19
por: Hamazaki, Kenya, et al.
Publicado: (2022) -
Autoimmune Hepatitis Associated With Cryoglobulinemic Vasculitis
por: Gouveia, Pedro Alves da Cruz, et al.
Publicado: (2022) -
Rituximab therapy for hepatitis C virus‐associated cryoglobulinemic membranoproliferative glomerulonephritis
por: Koratala, Abhilash, et al.
Publicado: (2018)